US 9597302
Combination of dofetilide and mexiletine for the prevention and treatment of atrial fibrillation
granted A61KA61K31/138A61K31/18
Quick answer
US patent 9597302 (Combination of dofetilide and mexiletine for the prevention and treatment of atrial fibrillation) held by Heart Rhythm Solutions, Inc. expires Mon Mar 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Heart Rhythm Solutions, Inc.
- Grant date
- Tue Mar 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/138, A61K31/18, A61K9/0053, A61K9/48